Friday, June 08, 2018 9:18:26 AM
Systems Inc. (CSE: LDS), (OTCQX: LDSYF), (Frankfurt: LD6, WKN: A14XHT)
announces updates on trademark filings and scheduling of clinical trials for
bio-availability of its CannaStripsTM technology.
The CannaStripsTM logo and tagline "Smoke Free Pain Relief" have been issued
European Union trade mark registration numbers 017383712 and 017383738 by
the European Union Intellectual Property Office and the United Kingdom trade
mark registration numbers UK00003265774 and UK00003265768, issued by the
United Kingdom Intellectual Property Office. The Company has also applied
for trademark protection in California. These marks are in addition to the
Canadian trademark applications the Company has filed with the Canadian
Intellectual Property Office on April 25, 2017.
The Company is scheduling clinical trials to commence in June 2018 to define
the bio-availability benefits of the Lifestyle Delivery Systems'
CannaStripsTM technology. These clinical trials are expected to quantify the
enhanced delivery method of CannaStripsTM compared to other forms of
delivery.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM